Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC

Clinical trial NCT07085234 · RECRUITING

Trial details

NCT number: NCT07085234
Sponsor: The First Affiliated Hospital of Xiamen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Nasopharyngeal Carcinoma Immunotherapy Induction Therapy

Start date: 2025-07-30
Primary completion: 2027-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.